FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/09/2023
Voltar para busca
Dado oficial do USPTO
PLEXPLUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PLEXPLUS
ST13
US500000079337468Classe
1, 5, 10, 42, 44
Pedido
79337468
Registro
7057884
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
17/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42, 44
Data de depósito
27/09/2021
Data de registro
23/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/05/2023
Última transação
23/05/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
HESIK, APRIL
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SpeeDx Pty Ltd
Representantes
Joi A. White Carr & Ferrell LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and science; chemical preparations for use in photography; chemicals for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; reagents and reactants in this class for scientific and research usemedical research usenonmedical use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Classe 5
Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; clinical diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Classe 10
Surgical apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits consisting primarily of diagnostic testing apparatus and instruments for the purpose of detecting antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; point of care medical devices being diagnostic testing apparatus for the purpose of detecting antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of diseasedetection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired and inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Classe 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicaldnarnaproteinpolynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencinganalysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experimentsthe results of scientific and medical experiments and teststhe analysis and evaluation of scientific and medical datadata generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of diseasedetection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; custom design and development of biochemical assays
Classe 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dnagenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine; molecular medical diagnostics testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/08/2023
FIMP
FINAL DISPOSITION PROCESSED
28/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
23/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/03/2023
PUBO
PUBLISHED FOR OPPOSITION
07/03/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/02/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/01/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
27/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
27/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/01/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
19/01/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
17/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/12/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/12/2022
RFNT
REFUSAL PROCESSED BY IB
20/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/06/2022
RFRR
REFUSAL PROCESSED BY MPU
29/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/06/2022
CNRT
NON-FINAL ACTION WRITTEN
28/06/2022
DOCK
ASSIGNED TO EXAMINER
28/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PLEXPLUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.